Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3191332 | Annals of Allergy, Asthma & Immunology | 2014 | 6 Pages |
Abstract
Physicians reported excellent outcomes using primarily newer STP therapies, namely plasma-derived C1 inhibitor, which was discordant to patient-reported outcomes using older STP therapies, namely anabolic steroids. Well-controlled STP studies are needed to clarify use for patients with HAE in the United States.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Maya K. MD, Umesh MD, PhD, Joyce MS, Jonathan A. MD,